# Chagas Disease (American Trypanosomiasis)

- Category: chronic
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: Chagas Disease - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK459272/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class AD24.01 - condition scope only, no dose · Egyptian drug register - availability only, no dose
- Verified date: 2026-09

## Verified against

- Chagas Disease - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK459272/, Treatment / Management (benznidazole 5-10 mg/kg/day divided q12h for 30-60 days; nifurtimox 8-10 mg/kg/day in 3 doses for 60-120 days)
- Egyptian drug register (neither benznidazole nor nifurtimox is marketed)

## Treatment metadata

- Benznidazole — 100 mg — oral.solid
- Recognition, travel history and referral (Referral & Advice)

## Complete treatment card

```text
CHAGAS DISEASE (AMERICAN TRYPANOSOMIASIS)
Sources: Chagas Disease - StatPearls - NCBI Bookshelf -
         https://www.ncbi.nlm.nih.gov/books/NBK459272/ · ICPC-3 (WONCA International Classification
         of Primary Care, 3rd edition) class AD24.01 - condition scope only, no dose · Egyptian drug
         register - availability only, no dose
Review status: REVIEWED against Chagas Disease - StatPearls - NCBI Bookshelf -
               https://www.ncbi.nlm.nih.gov/books/NBK459272/, Treatment /
               Management (benznidazole 5-10 mg/kg/day divided q12h for 30-60 days;
               nifurtimox 8-10 mg/kg/day in 3 doses for 60-120 days), Egyptian drug
               register (neither benznidazole nor nifurtimox is marketed)
               (2026-09)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (6)
    - Patients rarely recall or mention the triatomine bug bite itself
    - Acute illness often brings fever, localized swelling, enlarged lymph nodes, muscle aches,
      pallor, breathlessness and abdominal or chest pain  [abdominal pain · breathlessness · chest
      pain · fever · lymphadenopathy · muscle pain · pallor]
    - A minority develop an anaphylactic-type reaction to the bite, with hives, flushing, wheeze,
      nausea, vomiting and diarrhea  [diarrhoea · nausea · urticaria · vomiting · wheeze]
    - Congenital transmission can cause prematurity, low birth weight, fever, anemia and reduced
      muscle tone  [anaemia · fever]
    - Chronic cardiac disease can present with fever, an enlarged heart, apical aneurysms, ECG
      changes, or frank heart failure  [fever]
    - Chronic GI-phase Chagas can present with fever, megaesophagus, megacolon and constipation
      [constipation · fever]
  SIGNS - what you find (5)
    - One-sided conjunctivitis with purplish eyelid swelling, called Romana sign or a chagoma, is a
      hallmark finding  [eyelid swelling]
    - Cardiomegaly can show up as a displaced apical impulse, narrowed pulse pressure or sinus
      tachycardia  [tachycardia]
    - Right heart failure can bring bibasilar lung crackles and pitting swelling of both legs
      [crackles]
    - The abdomen can be distended but soft, with quiet bowel sounds, and rectal exam may find
      impacted stool
    - Exam may find an enlarged liver and spleen plus conjunctival pallor from chronic anemia
      [anaemia · hepatomegaly · pallor]
  TESTS (7)
    - Acute diagnosis relies on seeing the parasite by microscopy in fresh anticoagulated blood or
      buffy coat
    - PCR can turn positive days to weeks before a routine blood smear picks up circulating
      parasites
    - ECG, chest x-ray and echocardiography can all show cardiomegaly, and echo can reveal a reduced
      ejection fraction
    - ECG often shows first-degree AV block and atrial flutter or fibrillation, plus conduction
      defects such as right bundle branch block or left anterior fascicular block
    - Abdominal x-rays can show bowel pseudo-obstruction or an enlarged megacolon
    - Barium swallow or enema studies can be used to further evaluate GI symptoms
    - Chronic infection is confirmed by finding IgG antibodies against T. cruzi
  IF NOT THIS - what else fits (11)
    - Esophageal motility disorders belong on the differential list
    - Esophageal rupture belongs on the differential list
    - Esophageal spasm belongs on the differential list
    - Esophagitis belongs on the differential list
    - Gastroesophageal reflux disease belongs on the differential list
    - Leishmaniasis belongs on the differential list
    - Malaria belongs on the differential list
    - Meningitis belongs on the differential list
    - Myocardial infarction belongs on the differential list
    - Myocardial rupture belongs on the differential list
    - Congestive heart failure belongs on the differential list
  Source  StatPearls "Chagas Disease" - disease-level clinical article
  Status  traced to the source above

Rx: Antitrypanosomal treatment - specialist-sourced  |  Recognition and referral

ANTITRYPANOSOMAL TREATMENT - SPECIALIST-SOURCED
1. BENZNIDAZOLE                                           [1st line]
   Adult    5 to 10 mg/kg/day divided every 12 hours for 30 to 60 days. NOT MARKETED IN EGYPT -
            obtained through a tropical medicine centre x 30-60 days
   Peds     5-10 mg/kg/day
            (Divided every 12 hours, for 30 to 60 days. The article gives one
            weight-based regimen and says only that "Pediatric dosing also
            includes a 60-day weight-based regimen" without stating separate
            figures, so the same mg/kg/day range is shown here and no
            different paediatric number is invented. Treatment is most
            effective in children and in acute infection, which is why a child
            is the patient most likely to be treated.)
            3kg -> 15-30 mg/day     4kg -> 20-40 mg/day     5kg -> 25-50 mg/day
            6kg -> 30-60 mg/day     7kg -> 35-70 mg/day     8kg -> 40-80 mg/day
            9kg -> 45-90 mg/day     10kg -> 50-100 mg/day   11kg -> 55-110 mg/day
            12kg -> 60-120 mg/day   13kg -> 65-130 mg/day   14kg -> 70-140 mg/day
            15kg -> 75-150 mg/day   16kg -> 80-160 mg/day   17kg -> 85-170 mg/day
            18kg -> 90-180 mg/day   19kg -> 95-190 mg/day   20kg -> 100-200 mg/day
            21kg -> 105-210 mg/day  22kg -> 110-220 mg/day  23kg -> 115-230 mg/day
            24kg -> 120-240 mg/day  25kg -> 125-250 mg/day  26kg -> 130-260 mg/day
            27kg -> 135-270 mg/day  28kg -> 140-280 mg/day  29kg -> 145-290 mg/day
            30kg -> 150-300 mg/day  31kg -> 155-310 mg/day  32kg -> 160-320 mg/day
            33kg -> 165-330 mg/day  34kg -> 170-340 mg/day  35kg -> 175-350 mg/day
            36kg -> 180-360 mg/day  37kg -> 185-370 mg/day  38kg -> 190-380 mg/day
            39kg -> 195-390 mg/day  40kg -> 200-400 mg/day  41kg -> 205-410 mg/day
            42kg -> 210-420 mg/day  43kg -> 215-430 mg/day  44kg -> 220-440 mg/day
            45kg -> 225-450 mg/day  46kg -> 230-460 mg/day  47kg -> 235-470 mg/day
            48kg -> 240-480 mg/day  49kg -> 245-490 mg/day  50kg -> 250-500 mg/day
   Choice   The alternative, with its dose, from the same article: "Nifurtimox is the other
            antitrypanosomal therapy but is not currently FDA-approved. However, nifurtimox can be
            obtained through the Centers for Disease Control and Prevention (CDC) under an
            investigational protocol. Dosing is 8 to 10 mg/kg/day divided into 3 doses for 60 to 120
            days." Gastrointestinal effects are very common with it, and the more serious ones
            include neurotoxicity. A longer course, three times a day, harder to obtain, and no
            evidence that it works better - which is why benznidazole leads.
   Source   Chagas Disease - StatPearls - NCBI Bookshelf -
            https://www.ncbi.nlm.nih.gov/books/NBK459272/, Treatment / Management - verbatim:
            "Benznidazole was approved by the Food and Drug Administration (FDA) in 2017 with a
            recommended dosage of 5 to 10 mg/kg/day divided every 12 hours for 30 to 60 days."
            Availability from the Egyptian drug register
   Why      Antitrypanosomal. There are only two drugs for this infection and neither is clearly
            better: the article, citing the Pan American Health Organization guideline, records that
            "evidence to suggest which medication should be used as the first-line option is
            lacking; however, in the United States, benznidazole is used more often due to
            availability." Benznidazole leads here for the same reason - it is the one that is FDA-
            approved and can be obtained, whereas nifurtimox cannot.
   Caution  NOT MARKETED IN EGYPT. Neither benznidazole nor nifurtimox has any entry in the national
            drug register, so treatment cannot be started from a Cairo prescription. A suspected
            case is referred to a tropical medicine centre, which is also where the drug is sourced.
            The dose is printed here so the referring physician knows what is being arranged.
            RED FLAG - Two adverse effects are a reason to stop the drug at once, not to reduce it.
            The article: "A common adverse effect is dermatitis; more serious adverse effects
            include myelosuppression and peripheral neuropathy" and "The presence of
            myelosuppression or neuropathy is an indication to discontinue treatment immediately."
            That means a blood count and a neurological enquiry at every review during a course this
            long.
            The course is long and completion matters. Thirty to sixty days of twice-daily treatment
            with a drug that commonly causes a rash is hard to finish; the rash is the usual reason
            people stop. Warn about it in advance and review early.
            Not a Cairo diagnosis without a travel history. The triatomine ('kissing') bug that
            transmits it lives only in the Americas, so this is relevant to someone who lived in or
            travelled extensively through Latin America. Consider the travel history before anything
            else.
   Egypt    no Egyptian brand matched - prescribe by generic name


RECOGNITION AND REFERRAL
2. RECOGNITION, TRAVEL HISTORY AND REFERRAL (REFERRAL & ADVICE)[2nd line]
   Adult    Chronic protozoal infection spread by triatomine ('kissing') bugs found only in the
            Americas. Not a Cairo diagnosis except in someone who lived in or travelled extensively
            through Latin America; the specific drugs (benznidazole, nifurtimox) are not marketed in
            Egypt, so any suspected case needs referral to a tropical medicine centre. - Refer
   Peds     Children follow the same pathway: recognise and refer. No primary-care medicine is
            implied.
   Source   No dose - the recognition and referral pathway, from Chagas Disease - StatPearls - NCBI
            Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK459272/, Treatment / Management
   Why      Chronic protozoal infection spread by triatomine ('kissing') bugs found only in the
            Americas. Not a Cairo diagnosis except in someone who lived in or travelled extensively
            through Latin America; the specific drugs (benznidazole, nifurtimox) are not marketed in
            Egypt, so any suspected case needs referral to a tropical medicine centre.
   Caution  Not endemic in Egypt. Relevant to a returning traveller or an imported case; consider
            the travel history before anything else. The drug row above carries the dose that the
            receiving centre will use.
            RED FLAG - An acute febrile illness with periorbital swelling (Romana's sign) after a
            relevant exposure, or unexplained cardiomyopathy, megacolon or megaoesophagus in someone
            from an endemic area. The chronic complications are what usually bring the patient in,
            years later.
            Treatment is decided by a tropical medicine service, not started here - but the
            diagnosis is missed in primary care, which is where it matters. Both drugs work best in
            acute infection and in children, so recognising it early changes the outcome.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
